Revelation Biosc -CW27REVBWPreferred / convertible

13F holders, Q1 2024 (March 31)
12holders
1famous investor
$0.03avg. 13F price*

At the end of Q1 2024, 12 institutions reported holding Revelation Biosc -CW27 (REVBW) in their 13F filings. The largest holders were Linden Advisors LP ($9K), Yakira Capital Management, Inc. ($7K) and Walleye Capital LLC ($5K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Revelation Biosc -CW27
CUSIP
76135L119
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 12Q1 2024Q2 2024: 14Q2 2024Q3 2024: 13Q3 2024Q4 2024: 11Q4 2024Q1 2025: 9Q1 2025Q2 2025: 12Q2 2025Q3 2025: 11Q3 2025Q4 2025: 11Q4 2025Q1 2026: 11Q1 2026Q2 2026: 13Q2 2026

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 12 holders

Linden Advisors LP — Reduce -52.8% 338,110 $9K
Yakira Capital Management, Inc. — No change 246,884 $7K
Walleye Capital LLC — No change 187,001 $5K
Pine Valley Investments Ltd Liability Co — Reduce -50.2% 145,006 $4K
Walleye Trading LLC — No change 104,990 $3K
Cowen and Company, LLC — Reduce -0.2% 99,900 $3K
Wolverine Asset Management LLC — No change 72,202 $2K
Jane Street Group, LLC — No change 50,000 $1K
Citadel Advisors — Add +226.3% 46,527 $1K
Privium Fund Management B.V. — No change 44,000 $1K
Equitec Proprietary Markets, LLC — No change 20,000 $530
POM Investment Strategies, LLC — No change 1,005 $27

"% of holder's portfolio" is REVBW's weight in each manager's 13F, not the share of Revelation Biosc -CW27 the manager owns.